33 related articles for article (PubMed ID: 38674026)
1. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
[TBL] [Abstract][Full Text] [Related]
2. EGFR amplification is a real independent prognostic impact factor between young adults and adults over 45yo with wild-type glioblastoma?
Armocida D; Pesce A; Frati A; Santoro A; Salvati M
J Neurooncol; 2020 Jan; 146(2):275-284. PubMed ID: 31889239
[TBL] [Abstract][Full Text] [Related]
3. The TERT promoter mutation status and MGMT promoter methylation status, combined with dichotomized MRI-derived and clinical features, predict adult primary glioblastoma survival.
Shu C; Wang Q; Yan X; Wang J
Cancer Med; 2018 Aug; 7(8):3704-3712. PubMed ID: 29984907
[TBL] [Abstract][Full Text] [Related]
4. Molecular subtyping of glioblastoma based on immune-related genes for prognosis.
Chen X; Fan X; Zhao C; Zhao Z; Hu L; Wang D; Wang R; Fang Z
Sci Rep; 2020 Sep; 10(1):15495. PubMed ID: 32968155
[TBL] [Abstract][Full Text] [Related]
5. Potential Diagnostic and Clinical Significance of Selected Genetic Alterations in Glioblastoma.
Tomoszková S; Škarda J; Lipina R
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674026
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives.
Szopa W; Burley TA; Kramer-Marek G; Kaspera W
Biomed Res Int; 2017; 2017():8013575. PubMed ID: 28316990
[TBL] [Abstract][Full Text] [Related]
7. A novel literature-based approach to identify genetic and molecular predictors of survival in glioblastoma multiforme: Analysis of 14,678 patients using systematic review and meta-analytical tools.
Thuy MN; Kam JK; Lee GC; Tao PL; Ling DQ; Cheng M; Goh SK; Papachristos AJ; Shukla L; Wall KL; Smoll NR; Jones JJ; Gikenye N; Soh B; Moffat B; Johnson N; Drummond KJ
J Clin Neurosci; 2015 May; 22(5):785-99. PubMed ID: 25698544
[TBL] [Abstract][Full Text] [Related]
8. Liquid Biopsy in Glioblastoma Management: From Current Research to Future Perspectives.
Gatto L; Franceschi E; Di Nunno V; Tosoni A; Lodi R; Brandes AA
Oncologist; 2021 Oct; 26(10):865-878. PubMed ID: 34105205
[TBL] [Abstract][Full Text] [Related]
9. Recent advances of the regulation roles of MicroRNA in glioblastoma.
Yan C; Kong X; Gong S; Liu F; Zhao Y
Int J Clin Oncol; 2020 Jul; 25(7):1215-1222. PubMed ID: 32347433
[TBL] [Abstract][Full Text] [Related]
10. Systems Biology Approaches to Decipher the Underlying Molecular Mechanisms of Glioblastoma Multiforme.
Kaynar A; Altay O; Li X; Zhang C; Turkez H; Uhlén M; Shoaie S; Mardinoglu A
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948010
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance.
Montella L; Cuomo M; Del Gaudio N; Buonaiuto M; Costabile D; Visconti R; Di Risi T; Vinciguerra R; Trio F; Ferraro S; Bove G; Facchini G; Altucci L; Chiariotti L; Della Monica R
Int J Cancer; 2023 Aug; 153(3):476-488. PubMed ID: 36479695
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
